Related Experiment Video
Updated: Jun 20, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Cardiac challenges in patients with Fabry disease
F Weidemann1, A Linhart, L Monserrat
1Department of Medicine I, Center of Cardiovascular Medicine, Würzburg, Germany. weidemann_f@medizin.uni-wuerzburg.de
Fabry disease, a genetic disorder causing heart problems, requires early diagnosis for effective enzyme replacement therapy (ERT). Identifying Fabry cardiomyopathy in at-risk patients can lead to timely intervention and improved outcomes.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Fabry disease is an X-linked lysosomal storage disorder.
- It is a significant cause of hypertrophic cardiomyopathy (HCM), leading to heart failure and arrhythmias.
- The complex pathophysiology of Fabry cardiomyopathy is not fully understood.
Purpose of the Study:
- To emphasize the importance of early diagnosis for Fabry disease.
- To highlight the role of enzyme replacement therapy (ERT) in managing Fabry cardiomyopathy.
- To promote screening of at-risk cardiology patients for Fabry disease.
Main Methods:
- Enzymatic assays for early detection of Fabry disease.
- Genetic testing to confirm Fabry disease diagnosis.
- Cardiac evaluation of patients with hypertrophic cardiomyopathy (HCM) of unknown origin.
Main Results:
- Early diagnosis of Fabry disease allows for timely intervention with ERT.
- Screening HCM patients may identify undiagnosed Fabry disease cases.
- Identifying affected family members through genetic mapping is possible.
Conclusions:
- Early diagnosis and intervention are crucial for managing Fabry disease and its cardiac manifestations.
- ERT is most effective when initiated before significant cardiac hypertrophy or fibrosis develops.
- Screening selected cardiology patients can improve outcomes for individuals with Fabry disease.
More Related Videos
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy